<a href="https://biosciences.ricoh.com">Home</a> <span class="separator et-pb-icon">5</span> Events 5 Event 5 Ricoh Biosciences at the 2026 ALS Drug Development Summit

CONFERENCE

5th Annual ALS Drug Development
Summit

📅 June 2 – 4, 2026  
📍 The Colonnade  

Event Overview

Ricoh Biosciences is proud to be a Program Partner for the 5th Annual ALS Drug Development Summit taking place June 2 – 4 in Boston, MA. This meeting brings together leaders across biopharma, translational research, and clinical development to advance the next generation of ALS and FTD therapeutics.

Connect with Ricoh Biosciences to learn how our patient-derived iPSC models and disease-relevant functional assays are supporting more biologically relevant approaches to neurodegenerative disease research and drug development. We look forward to meeting with collaborators focused on accelerating progress in ALS, FTD, and related disorders.

Event Details

Location
The Colonnade,
Boston, MA, USA
Dates
June 2, 2026 –
June 4, 2026
Presentation
June 3rd @ 11:30 AM

Workshop/Seminar Presentation

Stop by our presentation to dive deeper into our research:

SEMINAR
Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization

📅 Wednesday, June 3rd  
⏰ 11:30 AM  
👤 Tetsuya Tanaka, Ph.D.  
💡 Disease Modeling  

Meet Our Team at the Conference

Tetsuya Tanaka

Tetsuya Tanaka, Ph.D.
VP, Stem Cell Biology

Henry Hunter

Henry Hunter
Director, Business Development

Marama Diaz-Asper

Marama Diaz-Asper
Manager, Business Development

Schedule a Meeting

Meet with our team during the event to discuss how we can support your discovery and translational programs.

Request a Meeting